GenSight Biologics Announces the Closing of the Company’s c. €4 Million Private Placement

GenSight Biologics Announces Successful Completion of a Private Placement of Close to EUR 4 Million

GenSight Biologics Announces the Filing of its 2024 Universal Registration Document

GenSight Biologics Reports Cash Position as of March 31, 2025, and Provides Business Update

GenSight Biologics Confirms Definitive Full-Year 2024 Consolidated Financial Results Are in Line with Estimates

GenSight Biologics announces financing amounting to c. €0.9 million from existing investors

GenSight Biologics Reports Estimated Full-Year 2024 Consolidated Financial Results

GenSight Biologics Reports End-of-Year Cash Position and Provides Business Update

GenSight Biologics announces a financing for an amount of c. €1.5 million from existing investors

GenSight Biologics Provides Update on Regulatory Discussions and Financial Situation